Vincent Shier

Vince regularly works with venture capital firms, private equity portfolio companies, startup biotechnology companies, and small-mid cap biotechnology and pharmaceutical companies. In this capacity, Vince advises venture capital firms on investable technologies and identification of complementary IP for in-licensing, as well as building developing strategies for portfolio companies to strategically align development of patent portfolios with company growth and objectives.

Vince represents clients in the biotechnology, life sciences, and pharmaceutical fields, as well as many chemical disciplines. These technologies include genetics, molecular biology, therapeutic methods, pharmaceuticals, DNA microarray technology, protein engineering, diagnostics, plants, FoodTech including alternate protein and cultivated meats, AgriTech, renewable energies, batteries, plastics, surface materials, minerals and mineral applications, along with an array of other chemical products and processes.

Prior to joining Brown Rudnick, Vince was a partner at an AmLaw100 law firm.